Myomo (MYO) Operating Income (2016 - 2025)
Myomo (MYO) posted Operating Income of -$3.5 million for Q3 2025, up 23.37% on a QoQ basis from -$4.6 million in Q2 2025, and down 267.34% year-over-year from $2.1 million in Q3 2024.
Myomo (MYO) Operating Income (2016 - 2025) Analysis & Trends
Myomo's Operating Income history runs 10 years deep, the most recent figure standing at -$3.5 million for Q3 2025.
- Quarterly Operating Income fell 267.34% year-over-year to -$3.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$11.9 million (down 41.44% YoY) and the FY2024 annual result came in at -$6.2 million, up 24.6% from the prior year.
- Operating Income was -$3.5 million for Q3 2025 at Myomo, up from -$4.6 million in the prior quarter.
- Across five years, Operating Income topped out at -$245314.0 in Q4 2024 and bottomed at -$4.6 million in Q2 2025.
- A 5-year average of -$2.5 million and a median of -$2.7 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2024 — Operating Income surged 89.92% — and 2025, when it sank 311.66%.
- Myomo's Operating Income stood at -$2.7 million in 2021, then gained by 17.61% to -$2.2 million in 2022, then retreated by 9.14% to -$2.4 million in 2023, then jumped by 89.92% to -$245314.0 in 2024, then slumped by 1333.88% to -$3.5 million in 2025.
- Business Quant data shows MYO's Operating Income at -$3.5 million in Q3 2025, -$4.6 million in Q2 2025, and -$3.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.52 Mn |
| Jun 30, 2025 | -4.59 Mn |
| Mar 31, 2025 | -3.52 Mn |
| Dec 31, 2024 | -245,314.00 |
| Sep 30, 2024 | -957,553.00 |
| Jun 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | -3.89 Mn |
| Dec 31, 2023 | -2.43 Mn |
| Sep 30, 2023 | -2.02 Mn |
| Jun 30, 2023 | -1.10 Mn |
| Mar 31, 2023 | -2.67 Mn |
| Dec 31, 2022 | -2.23 Mn |
| Sep 30, 2022 | -2.82 Mn |
| Jun 30, 2022 | -2.90 Mn |
| Mar 31, 2022 | -2.74 Mn |
| Dec 31, 2021 | -2.71 Mn |
| Sep 30, 2021 | -2.03 Mn |
| Jun 30, 2021 | -2.60 Mn |
| Mar 31, 2021 | -2.93 Mn |
| Dec 31, 2020 | -1.69 Mn |